The Influence of Standardized Process Management of Laryngeal Mask Airway Placement Based on Pressure Monitoring on the Incidence of Adverse Reactions in Elderly Patients During the Perioperative Period
Launched by XUANQI YANG · Apr 30, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a standardized way of managing the placement of a device called a laryngeal mask airway (LMA) can help reduce problems for elderly patients during surgery. The LMA is used to keep the airway open and is often preferred over traditional methods because it is easier to use and causes less discomfort. However, if it is not placed correctly, it can lead to complications such as sore throat or even more serious issues, particularly in older adults who may have other health concerns. The researchers want to find out if better management and monitoring of the LMA can lower these risks.
To be eligible for the trial, participants must be at least 60 years old and scheduled for certain types of elective surgeries that are expected to last between 30 minutes and 2 hours. They should also be in relatively good health, with no severe breathing problems or other conditions that could complicate the surgery. If you decide to take part in this study, you can expect to receive careful monitoring of the LMA during your surgery, which aims to make the experience safer and more comfortable. This research is important because it could lead to improved practices that benefit older patients during their surgical procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥60 years old
- • Non-cardiothoracic surgery and head and neck surgery
- • Elective surgery
- • ASA I-III grade
- • NYHA cardiac function class I-II
- • The operation time is expected to be ≥30 minutes and ≤2 hours
- • 18.5≤BMI (kg/m2) ≤24.9
- Exclusion Criteria:
- • Change to emergency surgery
- • Difficult airway that can be predicted before operation, such as difficulty in opening mouth and limited neck movement
- • Loose teeth
- • Laryngeal obstruction, laryngeal edema, laryngeal abscess, acute airway inflammation, full stomach, acute abdomen, abdominal trauma, drug poisoning, gastrointestinal bleeding
- • Complicated with chronic obstructive pulmonary disease, asthma and other respiratory diseases
- • Allergic to laryngeal mask materials
- • Non-supine position
- • Inability to cooperate with the investigator for any reason
- • Taking other investigational drugs or participating in other clinical trials within 3 months before study entry
- • The investigators considered it inappropriate to be included in the study
About Xuanqi Yang
Xuanqi Yang is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a strong emphasis on scientific rigor and ethical standards, Xuanqi Yang oversees the design, implementation, and management of clinical trials aimed at evaluating new therapies and interventions. The organization collaborates with healthcare professionals, researchers, and regulatory bodies to ensure that trials are conducted efficiently and in compliance with all applicable guidelines. Through a patient-centered approach, Xuanqi Yang strives to contribute valuable insights to the medical community and improve patient outcomes across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported